To control pain after breast surgery

To study the effect of local wound infiltration of Bupivacaine versus Bupivacaine with Ketamine versus Bupivacaine with Dexmedetomidine postoperatively in Mastectomy - BKDM

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035933

Enrollment

Registered

2021-08-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D249- Benign neoplasm of unspecified breast

Interventions

Intervention1: Bupivacaine: Bupivacaine, Bupivacaine with ketamine, Bupivacaine with dexmedetomidine

Eligibility

Inclusion criteria

Inclusion criteria: Female patients, who are posted for mastectomy of ASA 1 & 2 status between the age of 20 - 60 years.

Exclusion criteria

Exclusion criteria: Not willing to participate, Allergic to study drugs, taking other pain killers, Uncontrolled Diabetics, Chronic Alcoholic.

Design outcomes

Primary

Measure	Time frame
Assessment of Pain by VAS Scale, Time of request for 1st rescue analgesia. Total fentanyl consumption in 24hrs.Timepoint: Assessment of Pain by VAS Scale, Time of request for 1st rescue analgesia. Total fentanyl consumption in 24hrs.	—

Secondary

Measure	Time frame
Ramsay sedation Score, nausea, vomiting, deliriumTimepoint: within 24 hrs.	—

Countries

India

Contacts

Public ContactDr Shio Priye

RIMS, Ranchi

priyanka4ofice@gmail.com7488103644

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026